<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04137419</url>
  </required_header>
  <id_info>
    <org_study_id>2019-2-1</org_study_id>
    <nct_id>NCT04137419</nct_id>
  </id_info>
  <brief_title>Probiotics as Adjunct to Nonsurgical Periodontal Treatment</brief_title>
  <official_title>Probiotics as Adjunct to Nonsurgical Periodontal Treatment, Double Blinded Randomized Controled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ljubljana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ProlacSan probiotic lozenges and gels contain L. plantarum and L. brevis strains with proven
      in vitro antimicrobial activity against P. gingivalis. In our study we aim to investigate
      proposed benefit of ProlacSan as adjunct to conventional initial periodontal treatment in a
      group (n = 40) of Grade III and IV periodontitis patients. Patients will be randomized in two
      groups receiving either probiotic (n = 20) or placebo (n = 20) after completion of
      nonsurgical treatment within 7 days. Before treatment and after three months, standard
      periodontal parameters will be measured by masked examiner and plaque samples harvested for
      cultivation of 9 most relevant periodontal pathogens. One lozenge per day of
      probiotic/placebo will be used during 3 months healing period. Primary outcome measures will
      be the number of persisting sites per patient that need additional surgical treatment defined
      as sites with probing depth &gt; 4 mm and bleeding on probing.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 11, 2018</start_date>
  <completion_date type="Actual">April 30, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Placebo, masked evaluator</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Residual diseased site number</measure>
    <time_frame>3 months</time_frame>
    <description>No of sites with probing pocket depth (PPD) &gt; 4 mm and bleeding on probing after treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gingival bleeding index</measure>
    <time_frame>3 months</time_frame>
    <description>Percentage od bleeding sites after gentle probing of gingival sulcus</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Probing pocket depth reduction</measure>
    <time_frame>3 months</time_frame>
    <description>Change in probing pocket depth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recession</measure>
    <time_frame>3 months</time_frame>
    <description>Change of the position of the gingival margin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>3 months</time_frame>
    <description>Bleeding after measurement of pocket depth</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>ProlacSan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will get ProlacSan lozenges after nonsurgical treatment of periodontitis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will get placebo lozenges after nonsurgical periodontal treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic lozenges</intervention_name>
    <description>Probiotic strains</description>
    <arm_group_label>ProlacSan</arm_group_label>
    <other_name>ProlacSan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Similar to ProlacSan lozenges in taste in colour</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  periodontitis stage III or IV

          -  at least 20 teeth for evaluation

          -  besides solitary crowns, no other prosthodontic tooth replacements

          -  good systemic health

          -  smoking less than 10 cig/day

        Exclusion Criteria:

          -  periodontal treatment lass than 1 year before inclusion

          -  antibiotic therapy in the last 6 months

          -  chronic systemic diseases with the impact on periodontium or healing process

          -  medication with the impact on periodontium or healing process
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rok Gašperšič, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assist. prof.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Dental Clinic</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 16, 2019</study_first_submitted>
  <study_first_submitted_qc>October 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2019</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ljubljana</investigator_affiliation>
    <investigator_full_name>Rok Gašperšič</investigator_full_name>
    <investigator_title>Assist. Prof.</investigator_title>
  </responsible_party>
  <keyword>Periodontitis</keyword>
  <keyword>Probiotic</keyword>
  <keyword>Non-surgical therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

